• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. Brainstorm Health

Brainstorm Health

Page 10 of 83

Nestle Aimmune Peanut Allergy Drug
Newsletters

Nestlé invests another $200 million in Aimmune’s peanut allergy drug

By Sy Mukherjee
February 6, 2020
What Andreessen’s ‘Bio Fund III’ means for healthcare
Newsletters

What Andreessen’s ‘Bio Fund III’ means for healthcare

By Sy Mukherjee
February 5, 2020
A vaccine that looked promising for HIV doesn’t work
Newsletters

A vaccine that looked promising for HIV doesn’t work

By Sy Mukherjee
February 4, 2020
Vertex Pharmaceuticals Earnings 2019
Newsletters

Vertex CEO takes an earnings victory lap right before he exits

By Sy Mukherjee
January 31, 2020
Eli Lilly Earnings Diabetes Sales
Newsletters

Eli Lilly smashed Wall Street projections thanks to its diabetes drugs

By Sy Mukherjee
January 30, 2020
Novartis Zolgensma Gene Therapy Sales
Newsletters

Why a drug that costs $2.1 million per dose is on a sales streak

By Sy Mukherjee
January 29, 2020
Bloomberg Drug Prices
Newsletters

One drug, one patent?

By Sy Mukherjee
January 29, 2020
Kobe Bryant Death Science of Grief
Newsletters

Kobe Bryant and the science of grief

By Sy Mukherjee
January 28, 2020
China Coronavirus Vaccine
Newsletters

The hunt for a coronavirus vaccine begins

By Sy Mukherjee
January 24, 2020
American Well CEO Telehealth
Newsletters

Exclusive: American Well’s next act is turning your bedroom into a hospital

By Sy Mukherjee
January 23, 2020
FDA Sarepta Drug Approval Controversy
Newsletters

Does the FDA need to slow its drug approval roll?

By Sy Mukherjee
January 22, 2020
China coronavirus U.S. case CDC
Newsletters

The CDC says the deadly coronavirus from China has now come to the U.S.

By Sy Mukherjee
January 22, 2020
Most Active States CDC
Newsletters

The most active states in America

By Sy Mukherjee
January 17, 2020
Fitbit Flu Study
Newsletters

Could Fitbit be a flu warning tool?

By Sy Mukherjee
January 17, 2020
Fortune Brainstorm Updates
Newsletters

Changes are abound. Here’s what you should know

By Sy Mukherjee
January 16, 2020

Most Popular

  • Success
    Billionaire who sold two companies to Coca-Cola says he tries to convince people not to become entrepreneurs: 'Every...
    By Dave Smith
  • Success
    Healthcare is the one profession growing right now—and according to OpenAI CEO Sam Altman, it may be the only one...
    By Jessica Coacci
  • AI
    Ray Dalio calls for wealth 'redistribution policy' when AI and humanoid robots start to benefit the 1% to 10% more than...
    By Nick Lichtenberg
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.